Recursion Pharmaceuticals Inc

20 oct. 2026, 23:02 UTC

Recursion Pharmaceuticals Inc shares are trading modestly lower in after-market hours, with approximately $561 million in cash at the end of the quarter.

19 oct. 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is advancing in after-market trading, maintaining an upward trajectory since Monday's close.

17 oct. 2026, 00:01 UTC

Recursion Pharmaceuticals Inc shares advanced modestly higher during after-market hours on Friday, diverging from the recent trend of higher daily closes.

16 oct. 2026, 23:06 UTC

Recursion Pharmaceuticals Inc shares are modestly higher in after-market trading.

15 oct. 2026, 20:03 UTC

Recursion Pharmaceuticals announces a $200 million oversubscribed follow-on offering and positive updates on drug candidate REC-4881, achieving a 47% median reduction in polyp burden.

14 oct. 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, aligning with broader market losses amid rising inflation concerns and geopolitical tensions affecting oil supply.

13 oct. 2026, 23:06 UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours following Tuesday's close.

12 oct. 2026, 20:02 UTC

Recursion Pharmaceuticals Inc shares are sharply lower, continuing a downward trend since Friday, despite an early spike in today's trading session.

10 oct. 2026, 00:01 UTC

Recursion Pharmaceuticals Inc shares advanced during after-market hours on Friday, despite earlier pulling back from a session high.

9 oct. 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is trading modestly higher in after-market hours, recovering from an earlier decline while remaining well above its 20-day moving average.

8 oct. 2026, 20:01 UTC

Recursion Pharmaceuticals faces downward pressure amid significant insider transactions, including a 50k share sale by Director Borgeson Blake on October 6.

7 oct. 2026, 23:05 UTC

Recursion Pharmaceuticals Inc is trading lower in after-market hours, continuing a trend of three consecutive sessions finishing lower since Wednesday's close.

6 oct. 2026, 20:02 UTC

Recursion Pharmaceuticals Inc. shares fell amid sector declines, with attention on upcoming Phase 2 data for REC-4881 and ongoing trials for other candidates.

5 oct. 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, continuing lower since Monday's close, despite remaining above its 20-day moving average.

2 oct. 2026, 20:07 UTC

Recursion Pharmaceuticals Inc is trading higher, supported by a favorable market environment and positive sentiment following recent labor statistics.

1 oct. 2026, 23:01 UTC

Recursion Pharmaceuticals Inc saw modest gains in after-market hours, reaching a peak increase before settling lower, remaining near the upper end of its one-month range.

30 sept. 2026, 23:30 UTC

Recursion Pharmaceuticals Inc is trading higher in after-market hours, reflecting a broader market trend amid positive developments in technology and a revised U.S. GDP growth rate.

29 sept. 2026, 23:31 UTC

Recursion Pharmaceuticals Inc shares declined modestly in after-market trading, moving lower from Tuesday's close, currently around 0.74%, but above its 20-day moving average.

28 sept. 2026, 19:35 UTC

Recursion Pharmaceuticals Inc shares fell amid commentary on its role in AI-driven drug design, reflecting a decline since Friday's close.

25 sept. 2026, 23:50 UTC

Recursion Pharmaceuticals Inc has advanced in after-market trading, remaining above its 20-day moving average and near the upper end of its one-month trading range.

24 sept. 2026, 20:07 UTC

Recursion Pharmaceuticals is advancing amid a positive biotechnology trend, gaining alongside the ARK Genomic Revolution ETF, which benefits from favorable news from its holdings.

23 sept. 2026, 23:21 UTC

Recursion Pharmaceuticals Inc is advancing in after-market trading, rising sharply since Wednesday's close and remaining above its 20-day moving average.

22 sept. 2026, 19:50 UTC

Recursion Pharmaceuticals' stock is advancing after extending a data license agreement with Tempus AI, involving $42 million in committed payments over three years.

21 sept. 2026, 23:30 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, contrasting with recent gains, though it remains above its 20-day moving average.

19 sept. 2026, 00:01 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, moving lower since Friday's close, with notable momentum shifts observed during the session.

18 sept. 2026, 23:41 UTC

Recursion Pharmaceuticals Inc is declining in after-market trading, moving lower since Friday's close, despite remaining significantly above its 20-day moving average.

17 sept. 2026, 23:01 UTC

Recursion Pharmaceuticals Inc is trading modestly lower in after-market hours, moving in sympathy with Schrodinger Inc amid mixed economic indicators.

16 sept. 2026, 22:51 UTC

Recursion Pharmaceuticals Inc is moving higher in after-market trading, reflecting broader market gains following a sharp rise in U.S. retail sales in August.

15 sept. 2026, 23:02 UTC

Recursion Pharmaceuticals Inc. shares are higher in after-market trading, following the broader market's upward trend despite no specific company news.

14 sept. 2026, 20:08 UTC

Recursion Pharmaceuticals is gaining today, benefiting from Schrödinger's collaboration agreement with Tectora Therapeutics. Earlier, shares pulled back but have since recovered.